Agitation. You’ve felt it before. If you’re lucky, it’s fleeting and rare. But for thousands of people, persistent, inexplicable agitation can be an early and distressing sign of Alzheimer’s disease. It can appear in many forms and is not always severe:
Constantly moving around or pacing uncontrollably
Mood swings—going from calm to angry for no
reason
Becoming fixated on specific details
Feeling overwhelmed by a word that no longer makes
sense
The Escitalopram for Agitation in Alzheimer’s Disease (S-CitAD) study is being conducted to determine if a
study drug given as a pill can safely and effectively reduce the symptoms of agitation and aggression in
people with Alzheimer’s disease.
This study is funded by the people of America through a grant from
the National Institute on Aging. It has not received any funding from a pharmaceutical company.
Have an Alzheimer's diagnosis
Frequent symptoms of agitation or aggression
Caregiver or family member with the time
to spend several hours per week supervising care and accompanying the participant to study visits
Available for 3 months of follow-up
Do you or a loved one qualify?
Locations
To contact one of our study sites, click on the map or send an email to info@adtrial.org.
If you (or someone you know) have dementia and struggle with agitation, irritability, or similar behaviors, you might be eligible to participate.
